In VivoEnvironment Necessary to Support Transplanted Donor Mouse T Regulatory Cells

A Function for IL-7R for CD4+CD25+Foxp3+ T Regulatory Cells

(2014) A. L. Bayer et al.   JOURNAL OF IMMUNOLOGY

Clinical application of regulatory T cells in type 1 diabetes

(2013) Natalia Marek-Trzonkowska et al.   PEDIATRIC DIABETES

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

(2013) Stephen E Gitelman et al.   Lancet Diabetes & Endocrinology

Administration of CD4+CD25highCD127- Regulatory T Cells Preserves  -Cell Function in Type 1 Diabetes in Children

(2012) N. Marek-Trzonkowska et al.   DIABETES CARE

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

(2011) M. Di Ianni et al.   BLOOD

Expansion of a restricted residual host Treg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation

(2011) Allison L. Bayer et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Clinical tolerance in allogeneic hematopoietic stem cell transplantation

(2011) Maria-Grazia Roncarolo et al.   IMMUNOLOGICAL REVIEWS

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

(2011) Nicole Sherry et al.   LANCET

Treg-Therapy Allows Mixed Chimerism and Transplantation Tolerance Without Cytoreductive Conditioning

(2010) N. Pilat et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

(2010) C. G. Brunstein et al.   BLOOD

T regulatory cells and transplantation tolerance

(2010) Vijay S. Gorantla et al.   Transplantation Reviews

Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance

(2009) D. Adeegbe et al.   BLOOD

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years

(2009) Kevan C. Herold et al.   CLINICAL IMMUNOLOGY

IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice

(2009) Jinxing Xia et al.   CLINICAL IMMUNOLOGY

A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells

(2009) Aixin Yu et al.   IMMUNITY

Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT

(2008) A. L. Bayer et al.   BLOOD

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines

(2008) M. A. Morse et al.   BLOOD

Ex vivo expansion of CD4+CD25+T regulatory cells for immunosuppressive therapy

(2008) Piotr Trzonkowski et al.   CYTOMETRY PART A

Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells

(2008) P. Monti et al.   DIABETES

Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes

(2008) A. L. Putnam et al.   DIABETES

Homeostasis of Naive and Memory T Cells

(2008) Charles D. Surh et al.   IMMUNITY